Mercado Global de Entrega de Medicamentos – Tendências da Indústria e Previsão para 2029

Análise e dimensão do mercado

Nos últimos anos, prevê-se que o mercado de administração de medicamentos prolifere durante o período de previsão. De acordo com a Organização Mundial de Saúde (OMS), a prevalência de doenças crónicas deverá aumentar 57% até ao final de 2020, de acordo com a Organização Mundial de Saúde (OMS). O desejo de que os sistemas de saúde se concentrem mais em tecnologias avançadas de distribuição de medicamentos aumentou rapidamente em resposta ao aumento das doenças crónicas. Além disso, há uma ênfase crescente na segurança, eficácia e facilidade de utilização do produto para o doente. O mercado de distribuição de medicamentos aumentaria nos próximos anos devido à procura de tecnologias sofisticadas para satisfazer a crescente procura de produtos farmacêuticos injectáveis ​​de rotina para tratar doenças crónicas.

A Data Bridge Market Research analisa que o mercado de entrega de medicamentos foi avaliado em 1.458,19 milhões de dólares em 2021 e deverá atingir os 2.800,61 milhões de dólares até 2029, registando um CAGR de 8,50% durante o período de previsão de 2022 a 2029. O relatório de mercado com curadoria do A equipa de pesquisa de mercado da Data Bridge inclui análise especializada aprofundada, epidemiologia dos doentes, análise de pipeline, análise de preços e estrutura regulamentar.

Definição de mercado

A administração de medicamentos introduz um efeito terapêutico no corpo humano, fornecendo um medicamento a um determinado local-alvo. A segurança e a eficácia podem ser aumentadas através do ajuste da taxa, do tempo e da libertação do medicamento no organismo. Os medicamentos podem ser administrados de diversas formas, incluindo por via oral, injetável, pulmonar, nasal e outras. As características das nanopartículas têm sido estudadas e utilizadas para desenvolver sistemas de distribuição de fármacos, o que tornou o processo de distribuição de fármacos mais eficiente e rápido.

Âmbito do relatório e segmentação de mercado

Drug Delivery Market Dynamics

Drivers

• Rise in the prevalence of chronic diseases

The rising prevalence of chronic diseases is estimated to propel the drug delivery market's growth. Sedentary lifestyles have become commonplace as a result of rapid technological adoption. Obesity rates are rising as a result of this change in lifestyle, which is leading to a slew of chronic ailments such as diabetes and heart disease.

• Increasing investment for healthcare infrastructure

Another significant factor influencing the growth rate of drug delivery market is the rising healthcare expenditure which helps in improving its infrastructure.

Furthermore, rising initiatives by public and private organizations to spread awareness and technological advancement will expand the drug delivery market. Additionally, high disposable income and increasing adoption of advanced drug administration systems will result in the expansion of drug delivery market. Along with this, rising geriatric population and rising demand for biosimilars and biologics will enhance the market's growth rate.

Opportunities

• Increase in the number of research and development activities       

Moreover, the market's growth is fueled by an increase in the number of research and development activities. This will provide beneficial opportunities for the drug delivery market growth. Along with this, rising drug approvals and launch of innovative products will further propel the market's growth rate.

Moreover, rising investment for the development of advanced technologies and an increase in the number of emerging markets will further provide beneficial opportunities for the growth of the drug delivery market during the forecast period.

Restraints/Challenges

On the other hand, the increasing number of drug recalls and drug failures will obstruct the growth rate of market. The dearth of skilled professionals and lack of healthcare infrastructure in developing economies will challenge the drug delivery market. Additionally, the risk of needle stick injuries will restrain and further impede the market's growth rate during the forecast period of 2022-2029.

This drug delivery market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the drug delivery market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Patient Epidemiology Analysis

Drug delivery market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analyses of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.

COVID-19 Impact on Drug Delivery Market

Over the projected period, the drug delivery market is expected to be constrained by the COVID-19 outbreak. Since its emergence in December 2019, the COVID-19  virus has spread to nearly every country on the planet, prompting the World Health Organization (WHO) to declare it a public health emergency. COVID-19, a new coronavirus, was identified as the causal agent in the pneumonia cases. This virus spread quickly over the world, killing a large number of people. COVID-19 was labelled a global pandemic by the World Health Organization (WHO) in March 2020, and rigorous measures to prevent the disease's spread were recommended. Since then, the pandemic has delayed the expansion of the healthcare sector and disrupted the supply chain. Furthermore, governments in many nations have imposed nationwide lockdowns to halt the spread of COVID-19. Similarly, healthcare organizations in numerous nations throughout the world are having difficulty continuing their supply chain activities. The supply chain slowness has also hampered the drug delivery market.

Recent Development

• In March 2022, Sandoz, a Novartis division, announced the acquisition of a UK-based medical and drug delivery device company, Coalesce Product Development Limited. Sandoz acquired Coalesce's expertise and assets as part of the arrangement, which will help the company expand its respiratory medication portfolio and improve patient access to high-quality, complex therapeutics.

Global Drug Delivery Market Scope

The drug delivery market is segmented on the basis of product type, application, end-users and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Oral Drug Delivery
• Pulmonary Drug Delivery
• Injectable Drug Delivery
• Ophthalmic Drug Delivery
• Nasal Drug Delivery
• Topical Drug Delivery
• Implantable Drug Delivery
• Transmucosal Drug Delivery

On the basis of product type, the market is segmented into oral drug delivery, pulmonary drug delivery, injectable drug delivery, ophthalmic drug delivery, nasal drug delivery, topical drug delivery, implantable drug delivery and transmucosal drug delivery.

Application

• Cancer
• Diabetes
• Respiratory Diseases
• Cardiovascular Diseases
• Others

Based on application, the market is segmented into cancer, diabetes, respiratory diseases, cardiovascular diseases and others.

 End-Users

• Hospitals
• Specialty Clinics
• Homecare
• Others

On the basis of end-users, the drug delivery market is segmented into hospitals, specialty clinics, homecare and others.

Distribution Channel

• Hospital Pharmacy
• Retail Pharmacy
• Online Pharmacy
• Others

On the basis of distribution channel, the drug delivery market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.

Drug Delivery Market Regional Analysis/Insights

The Drug delivery market is analysed and market size insights and trends are provided by country, product type, application, end-users and distribution channel as referenced above.

The countries covered in the Drug delivery market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

A América do Norte domina o mercado de administração de medicamentos devido à presença de grandes players e de infraestruturas de saúde bem estabelecidas nesta região. Além disso, o aumento da prevalência de doenças crónicas e o desenvolvimento de medicamentos biológicos e farmacêuticos, bem como de dispositivos, impulsionará ainda mais a taxa de crescimento do mercado nesta região.

Prevê-se que a Ásia-Pacífico cresça durante o período de previsão devido à crescente população geriátrica e à possibilidade de auto-administração nesta região. Além disso, o desenvolvimento da infra-estrutura de cuidados de saúde impulsionará ainda mais a taxa de crescimento do mercado nesta região.

A secção do país do relatório também fornece fatores individuais de impacto no mercado e alterações na regulamentação do mercado interno que impactam as tendências atuais e futuras do mercado. Pontos de dados como a análise da cadeia de valor a jusante e a montante, tendências técnicas e análise das cinco forças de Porter, estudos de caso são alguns dos indicadores utilizados para prever o cenário de mercado para países individuais. Além disso, são considerados a presença e disponibilidade de marcas globais e os desafios enfrentados devido à grande ou escassa concorrência de marcas locais e nacionais, o impacto das tarifas nacionais e das rotas comerciais, ao mesmo tempo que se fornece uma análise de previsão dos dados do país.   

Análise do cenário competitivo e da quota de mercado de administração de medicamentos

O panorama competitivo do mercado de administração de medicamentos fornece detalhes por concorrente. Os detalhes incluídos são a visão geral da empresa, finanças da empresa, receitas geradas, potencial de mercado, investimento em investigação e desenvolvimento, novas iniciativas de mercado, presença global, localizações e instalações de produção, capacidades de produção, pontos fortes e fracos da empresa , lançamento de produto, largura e amplitude do produto, aplicação domínio. Os dados acima fornecidos estão apenas relacionados com o foco das empresas relacionado com o mercado de entrega de medicamentos.

Alguns dos principais players que trabalham no mercado de administração de medicamentos são:

• F. Hoffmann-La Roche Ltd. (Suíça)
• Mylan NV (EUA)
• Teva Pharmaceutical Industries Ltd.(Israel)
• Sanofi (França), Pfizer Inc.
• GlaxoSmithKline plc (Reino Unido)
• Novartis AG (Suíça)
• Sun Pharmaceutical Industries Ltd. (Índia)
• (Índia)
• Bausch Health Companies Inc. (Canadá)
• AstraZeneca (Reino Unido)
• Johnson & Johnson Private Limited (EUA)
• Merck & Co., Inc.
• Cadila Farmacêutica. (Índia)
• 3M (EUA)
• Bayer AG (Alemanha)
• Astellas Pharma Inc.
• (EUA)
• Takeda Pharmaceutical Company Limited (Japão) 

SKU-52812